• TBD Pharmatech attended Disc Golf competition

    TBD Pharmatech attended Disc Golf competition

    On 24th of September Ettevõtete Discgolf 10.0 aka disc golf competition between companies took place near Tallinn. It was the first time TBD Pharmatech attended an event like this but definitely not the last! TBD was represented by the team of three: Sander Kotkas, Jürgen Vahter and Merle Muruvee. In the general competition our team achieved 14th place out of 50 teams. In the individual putting competition we were very close to triumphing – Sander finished as second (out of ca 80 participants). Good job guys!

    Read more
  • TBD-Biodiscovery became TBD Pharmatech

    TBD-Biodiscovery became TBD Pharmatech

    On 22nd of September we changed our brand name from TBD-Biodiscovery to TBD Pharmatech. The legal name will remain TBD-Biodiscovery Ltd. The change of the name means a new logo with a fresh visual identity and a new website. The founder and CEO Andrus Tasa explained the need for the change: „When we started the company in 2006 the main aim was to refine substances from plants, hence the name TBD-Biodiscovery – to discover from plants. Over the years we turned more towards pharmacy and organic synthesis and the old name didn’t seem suitable anymore.“ The new name TBD Pharmatech

    Read more
  • Project: A breakthrough technology for dental root canal treatments to save teeth (EndoSolution)

    Project: A breakthrough technology for dental root canal treatments to save teeth (EndoSolution)

    The aim of this collaboration project is to develop a breakthrough technology in root canal treatment, specifically entirely novel endodontic filling material (Endofill) and a device to solidify the injectable material within the root canal (Fibercure). The product line is the first of its kind in the world and will completely revolutionize root canal treatments enabling any dentist to perform these treatments in a fast, simple and noninvasive manner and with a significantly higher treatment efficiency and success rate. The project is led by Lumendo AG together with three key partners: TBD-Biodiscovery (Tartu, Estonia) and Studio Mango (Breda, The Netherlands)

    Read more